LAmAb Biologics

LAmAb Biologics is a special purpose company aimed at developing a compound for proof of concept. The project is fully funded by TVM Life Science Innovations II. To date, the biopharmaceutical asset has completed humanization and will enter GLP toxicology studies and production in the coming months. Once clinical development approval is obtained from regulatory authorities, the LAmAb Biologics antibody will be tested in allergy patients.